|
|
||||||||
Correspondence to: Geneviève Renier, at Notre-Dame Hospital, Research Center, 3rd floor, Door Y-3622, 1560 Sherbrooke Street East, Montreal, Quebec, H2L 4M1., genevieve.renier{at}umontreal.ca (E-mail)
FH is associated with accelerated atherosclerosis. Based on the crucial role of macrophage LPL in atherogenesis, we determined in the present study macrophage LPL expression in patients with FH. Monocytes isolated from 13 FH patients and 13 control subjects were differentiated into macrophages by culturing the cells for 9 days in 20% autologous or heterologous serum. Macrophages of patients with FH cultured in their own sera showed a significant increase in LPL mRNA levels, extracellular LPL mass, and activity compared with macrophages of control subjects. Although these alterations positively correlated with the levels of serum platelet-derived growth factor-BB (PDGF-BB) in FH subjects, increased LPL secretion by cultured FH macrophages was reduced neither by immunoneutralizing FH serum with an anti-PDGF-BB antibody, nor by culturing these cells in sera from control subjects. With the exception of LPL, levels of other cytokines and 8-isoprostane were not increased in the supernatants of macrophages of FH patients. Serum from FH patients also enhances the levels of LPL secreted by macrophages from control subjects. Immunoneutralization of FH serum with an anti-PDGF-BB antibody totally reversed this alteration.
Overall, this study demonstrates that macrophages from FH subjects overproduce LPL and that PDGF present in the serum from FH patients stimulates LPL secretion by control macrophages. These findings suggest that macrophage LPL induction in patients with FH might be related to the increased atherogenesis observed in these subjects. Beauchamp, M-C., É. Letendre, and G. Renier. Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia. J. Lipid Res. 2002. 43: 215222.
Supplementary key words: atherosclerosis, platelet-derived growth factor, cytokines
This article has been cited by other articles:
![]() |
G. Qiu and J. S. Hill Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages J. Lipid Res., October 1, 2007; 48(10): 2112 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Qiu, A. C. Ho, W. Yu, and J. S. Hill Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion J. Lipid Res., February 1, 2007; 48(2): 385 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tentolouris, A. Stylianou, E. Lourida, D. Perrea, D. Kyriaki, E. C. Papavasiliou, A. D. Tselepis, and N. Katsilambros High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria J. Lipid Res., January 1, 2007; 48(1): 218 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Irvine, P. Foka, S. A. Rogers, J. R. Mead, and D. P. Ramji A critical role for the Sp1-binding sites in the transforming growth factor-{beta}-mediated inhibition of lipoprotein lipase gene expression in macrophages Nucleic Acids Res., March 8, 2005; 33(5): 1423 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Serri, L. Li, F. Maingrette, N. Jaffry, and G. Renier Enhanced Lipoprotein Lipase Secretion and Foam Cell Formation by Macrophages of Patients with Growth Hormone Deficiency: Possible Contribution to Increased Risk of Atherogenesis? J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 979 - 985. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |